 |
We built our Heart and Vascular Institute on the expertise of dozens of board-certified cardiologists and surgeons. Please use the directory below to find a doctor affiliated with the Heart and Vascular Institute, or call us anytime at 201-447-8456. |
 |
From atrial fibrillation to Wolff-Parkinson-White syndrome and every diagnosis in between, we will care for you like no other hospital. It´s the advanced cardiac care you need – when and where you need it most. Please click below for an overview of the conditions we treat. If you would prefer to speak with us, please call 201-447-8456.
View an A – Z listing of the conditions we treat |
We treat virtually every type of cardiac and vascular diagnosis. Our network of board-certified cardiologists and surgeons is dedicated to providing you with the highest level of specialized care. Please click below for an overview of the treatments and procedures we provide. If you would prefer to speak with us, please call 201-447-8456.
View an A – Z listing of the treatments and procedures we perform |
 |
Support the Heart & Vascular Institute
To learn more about how you can support our Heart & Vascular Institute please contact Steve Testa, Assistant Vice President of The Valley Hospital Foundation, at stesta@valleyhealth.com or 201-291-6377. Philanthropy plays a vital role in funding our cutting-edge research and innovative patient care programs, as well as maintaining our state-of-the-art facilities.
You may also donate online by clicking here. |
|
Clinical Trials
- DESERT
Drug Eluting Stent Event Registry of Thrombosis
- IMPROVE IT
Improved Reduction of Outcomes: Vytorin Efficacy International Trial
- Translate-ACS
Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns
and Events after Acute Coronary Syndrome (Translate-ACS) Registry
- TRILOGY/TABY
A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS) Subjects
with unstable Angina/Non-ST-Elevation Myocardial Infarction (UN/NSTEMI) Who are
Medically Managed
- Vest
The Vest Prevention of Early Sudden Death Trial
- VIRGO
Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction
(AMI) Patients
- Vista-16
Evaluation of the Safety and Efficacy of Short-Term A-002 Treatment in Subjects
with Acute Coronary Syndromes
- Bioflex-1
The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding
Astron and Astron Pulsar Stents
- Choice
Carotid Stenting for High Surgical Risk Patients; Evaluating Outcomes Through the
Collection of Clinical Evidence
- Dal-Plaque – 2
A Phase III, Multi-center, Double-Blind, Randomized, Placebo Controlled Study Evaluating
the Effect of Treatment with Dalcetrapib 600 mg on Atherosclerotic Disease as Measured
by
- ENDEAVOR RESOLUTE
A Clinical Evaluation of the Medtronic Endeavor® Resolute Zotarolimus-Eluting Coronary
Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with
a Reference Vessel Diameter of 2.25 mm to 4.2 mm
- HCRI DAPT
A prospective, multi-center, randomized, double-blind trial to assess the effectiveness
and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects
undergoing percutaneous coronary intervention (PCI) with either drug-eluting stent
(DES) or bare metal stent (BMS) placement for the treatment of coronary artery lesions
- XIENCE V™
Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study
- BIOCOR
Post-Approval Study Protocol of the St. Jude Medical Biocor™ and Biocor™ Supra Valve
- B.U.T.S
Collection of Blood, Urine, and Tissue Specimens to Study Cardiovascular Disease
- Cardiac Surgery Tissue Banking
The purpose of this research is to obtain some of the excess tissue that is left
over from surgeries for future research
- MST
Mechanical Strength Testing of Aortic Aneurysm Tissue The purpose of this study
is to test the strength of aneurysm tissue after it has been replaced during surgery
- Team-HF
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart
Failure
- TOPCAT
Treatment of Preserved Cardiac function heart failure with an Aldosterone anTagonist
- AIGIS Rx
Antibacterial Envelope for Prevention of Infection Following CRM Device Replacement
with an ICD. Citadel. PI. Mark Preminger, MD
- Block HF
Bi-V vs. RV Pacing in HF Patients with AV Block. Medtronic. PI. Suneet Mittal, MD
- Impact
The IMPACT of Biotronik Home Monitoring Guided Anticoagulation on Stroke Risk in
Patients with Implanted ICD and CRT-D devices
- MADIT-RIT
Boston Scientific, PI. Tina Sichrovsky, MD
- MADIT-RS
Risk Stratification/MADIT II Patients. NIH. PI. Aysha Arshad, MD
- PV ablation with LV Dysfunction
Pulmonary Vein Isolation for Rhythm Control in Patients with Atrial Fibrillation
and Left Ventricular Dysfunction: A Pilot Study
- ThermoCool®
ThermoCool® SmartTouch™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial
Fibrillation (PAF)
- Orbit-AF
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation
- Pallas
A randomized, double blind, placebo controlled, parallel group trial for assessing
the clinical benefit of dronedarone 400mg BID on top of standard therapy in patients
with permanent atrial fibrillation and additional risk factors
- Pegasus – TIMI 54
A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multinational Trial
to Assess the Prevention of Thrombotic Events with Tricagrelor Compared to Placebo
on a Backround of Acetyl Salicylic Acid (ASA) Therapy in Patients with History of
Myocardial Infarction
- PRECISION
A Randomized, Double Blind, Parallel-Group Study of Cardiovascular Safety in Osteoarthritis
or Rheumatoid Arthritis Patients With or at High Risk for Cardiovascular Disease
Comparing Celecoxib with Naproxen and Ibuprofen
Valley Specialized Services
|